PMC:7461420 / 75200-75364 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T892","span":{"begin":10,"end":18},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"Antiviral activity assays, using real‐time reverse transcription‐PCR, indicated that ebselen and inhibitor “N3” (40; Figure 12) had the strongest antiviral effects."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T420","span":{"begin":85,"end":92},"obj":"Chemical"},{"id":"T40554","span":{"begin":97,"end":106},"obj":"Chemical"},{"id":"T66228","span":{"begin":146,"end":155},"obj":"Chemical"}],"attributes":[{"id":"A28532","pred":"chebi_id","subj":"T420","obj":"http://purl.obolibrary.org/obo/CHEBI_77543"},{"id":"A43890","pred":"chebi_id","subj":"T40554","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A40670","pred":"chebi_id","subj":"T66228","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"}],"text":"Antiviral activity assays, using real‐time reverse transcription‐PCR, indicated that ebselen and inhibitor “N3” (40; Figure 12) had the strongest antiviral effects."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T66","span":{"begin":43,"end":64},"obj":"http://purl.obolibrary.org/obo/GO_0001171"},{"id":"T67","span":{"begin":51,"end":64},"obj":"http://purl.obolibrary.org/obo/GO_0006351"}],"text":"Antiviral activity assays, using real‐time reverse transcription‐PCR, indicated that ebselen and inhibitor “N3” (40; Figure 12) had the strongest antiviral effects."}

{"project":"LitCovid-sentences","denotations":[{"id":"T649","span":{"begin":0,"end":164},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Antiviral activity assays, using real‐time reverse transcription‐PCR, indicated that ebselen and inhibitor “N3” (40; Figure 12) had the strongest antiviral effects."}